Laughter Yoga and Sleep Hygiene Training for College Students With Premenstrual Syndrome (LYSHPMS)
2026年5月14日 更新者：Şengül Yaman Sözbir、Gazi University
The Effect of Laughter Yoga and Sleep Hygiene Training on Premenstrual Syndrome Levels, Perceived Stress Levels, and Sleep Quality Among University Students
This study aims to evaluate the effects of laughter yoga and sleep hygiene training on premenstrual syndrome (PMS) symptoms, perceived stress levels, and sleep quality among nursing students.Premenstrual syndrome is a common health issue characterized by physical symptoms as well as emotional fluctuations, anxiety, depressive mood, and behavioral changes, which can negatively impact quality of life.
Additionally, it is known that stress is a significant risk factor that exacerbates PMS symptoms, and that healthy lifestyle behaviors may be effective in alleviating these symptoms.
In this context, it has been reported that yoga and similar relaxation-based practices support mental well-being by reducing stress levels.The intervention consists of laughter yoga and sleep hygiene education, implemented as non-pharmacological methods over a 4-week period.Participants were assessed at baseline, immediately following the intervention, and during the 1-month follow-up period.
The primary objective is to observe improved sleep quality alongside reductions in PMS symptoms and stress levels in participants as a result of the intervention.
The findings are expected to contribute to the effectiveness of non-pharmacological, low-cost, and feasible approaches in managing PMS symptoms, as well as addressing stress and sleep quality.
調査の概要
詳細な説明
Premenstrual syndrome (PMS) is a common health issue characterized by emotional fluctuations, anxiety, depressive mood, and behavioral changes, in addition to physical symptoms that can negatively impact quality of life.
PMS can lead to a decline in quality of life by negatively affecting an individual's social life, psychological well-being, emotional balance, and dietary habits; in some individuals, it can develop into a severe condition that significantly restricts daily life.
Within the multifaceted nature of PMS, stress emerges as a significant risk factor; it is noted that stress can increase symptom severity, elevate the frequency of traumatic life experiences, and underlie sleep disturbances in individuals.
Deterioration in sleep quality further exacerbates this process, being associated with fatigue, emotional fluctuations, and a decline in overall well-being.
While non-pharmacological methods are used to mitigate or prevent these effects on the individual, laughter yoga-based interventions remain limited.
This study evaluates laughter yoga-a low-cost, feasible non-pharmacological method that incorporates simulated laughter, rhythmic breathing, gentle movements, and meditation-examining its effects on PMS management, stress-related hormone (cortisol) levels, and sleep quality.The intervention consisted of laughter yoga and sleep hygiene training administered over a 4-week period.
Sleep hygiene training was provided during the first session of laughter yoga.
Participants were assessed at different time points: at baseline, immediately following the intervention, and at the 1-month follow-up.
The primary objective of the study is to assess changes in PMS levels, stress, and sleep quality over time among university students and to determine the sustainability of the intervention's effects during the follow-up period.
This study contributes to the literature on nonpharmacological methods used to evaluate the effectiveness of interventions on PMS levels, stress, and sleep quality.
研究の種類
介入
入学 (実際)
45
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Ankara
-
Ankara、Ankara、トルコ（Türkiye）、06000
- Gazi University Institute of Health Sciences
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
説明
Inclusion criteria for the study:
- Female, 18 years of age or older
- Second-year nursing student (who has not yet taken the Women's Health and Diseases Nursing course)
- Having a regular menstrual cycle
- Scoring 45 or higher on the Premenstrual Syndrome Scale (PMS level is mild)
- Using the WhatsApp® app
Exclusion criteria for the study:
- Having any communication difficulties (mental, auditory, visual, etc.)
- Having previously participated in a stress management program
- Using pharmacological or non-pharmacological methods to manage PMS symptoms
- Having a chronic or neuropsychiatric condition
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Participants were enrolled in a 4-week laughter yoga program.They received training on sleep hygiene
intervention group
|
University students participated in 45-minute laughter yoga sessions held once a week for four weeks.
During the first session, participants received training on sleep hygiene and were given a brochure on the topic.
The sleep hygiene training covered the following topics: sleep, the importance of sleep, factors affecting sleep (circadian rhythm, sleep-wake cycle, nutrition, physical activity), factors causing poor sleep, sleep deprivation, and sleep hygiene.
|
|
介入なし：No interventions were made regarding the participants.
control grup
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in premenstrual syndrome levels
時間枠：Baseline, 4 weeks (end of intervention), 1-month follow-up
|
PMS levels and associated physical, emotional, and behavioral changes in participants were measured using a validated scale.
Changes in PMS levels were assessed by comparing the intervention and control groups.The Premenstrual Syndrome Scale (PSS) was used to evaluate the data.The scale consists of a total of 44 items and 9 subscales, organized on a 5-point Likert scale.
The scale is scored as follows: 1 = never, 2 = rarely, 3 = sometimes, 4 = often, and 5 = always.
Scores obtained from the scale can be calculated separately for each subscale or evaluated based on the total score.
The total scale score ranges from 44 to 220, and the presence of PMS is considered in individuals scoring 132 or higher.
Additionally, the severity of PMS is classified as follows: 44 points = no PMS, 45-103 points = mild PMS, 104-163 points = moderate PMS, and 164-220 points = severe PMS.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in perceived stress levels
時間枠：Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Participants' perceived stress levels were measured using a validated scale.
Changes in stress levels were assessed by comparing the intervention and control groups.
The Perceived Stress Scale (PSS) was used to analyze the data.The scale consists of a total of 14 items, each of which is rated on a 5-point Likert scale (0 = Never, 4 = Very often).
The scale consists of two subscales: low self-efficacy perception (items 4, 5, 6, 8, 9, 10, 13) and stress/distress perception (items 1, 2, 3, 7, 11, 12, 14).
Items 4, 5, 6, 7, 9, 10, and 13 are reverse-scored.
The lowest and highest possible scores a participant can achieve on this scale are 0 and 56, respectively.
An increase in the total score from the scale or its subscales indicates an increase in the individual's perceived stress level.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
|
Changes in sleep quality
時間枠：Baseline, 4 weeks (end of intervention), 1-month follow-up
|
Participants' sleep quality was measured using a validated scale.
Changes in sleep quality were assessed by comparing the intervention and control groups.
The assessment was conducted using the Pittsburgh Sleep Quality Index (PSQI).
The scale consists of 24 questions.
The first 18 questions, which the participant answers themselves, are used to calculate the total score and the subscale scores.
The 18 questions on the scale cover 7 components: sleep quality (component 1), sleep latency (component 2), sleep duration (component 3), habitual sleep efficiency (component 4), sleep disorder (component 5), sleep medication use (component 6), and daytime sleep dysfunction (component 7).
Each component is scored on a scale of 0-3.
The sum of these 7 component scores yields the total score.
The total score ranges from 0 to 21.
Individuals with a score of 5 or below are assessed as having "good" sleep quality, while those with a score above 5 are assessed as having "poor" sleep quality.
|
Baseline, 4 weeks (end of intervention), 1-month follow-up
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
捜査官
- 主任研究者：Şengül YAMAN SÖZBİR、Gazi University
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2026年3月1日
一次修了 (実際)
2026年5月1日
研究の完了 (実際)
2026年5月1日
試験登録日
最初に提出
2026年5月4日
QC基準を満たした最初の提出物
2026年5月14日
最初の投稿 (実際)
2026年5月20日
学習記録の更新
投稿された最後の更新 (実際)
2026年5月20日
QC基準を満たした最後の更新が送信されました
2026年5月14日
最終確認日
2026年5月1日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- EBS
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
IPD プランの説明
Data confidentiality and participant privacy will be strictly protected in accordance with applicable laws and regulations.
Individual participant data (IPD) will not be shared.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。